Glioblastoma organoids, lab-grown replicas of a patient's tumor, accurately predict how the tumor responds to CAR T cell therapy. This breakthrough allows real-time testing of therapies, showing that responses in the organoid closely mirror those in the patient.
Glioblastoma organoids, lab-grown replicas of a patient's tumor, accurately predict how the tumor responds to CAR T cell therapy. This breakthrough allows real-time testing of therapies, showing that responses in the organoid closely mirror those in the patient.
Share this Article
Recommended